Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

nisoldipine

nisoldipine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Sular TABLET, EXTENDED RELEASE, ORAL 8.5 mg, 17 mg, 25.5 mg, 34 mg    
Sular TABLET, EXTENDED RELEASE, ORAL 10 mg, 20 mg, 30 mg, 40 mg    
VIEW MORE Dihydropyridines
CLASS
242808
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

nisoldipine (Sular)

  • 10 mg extended release tablet oral Daily
  • 20 mg extended release tablet oral Daily
  • 30 mg extended release tablet oral Daily                                        
  • 40 mg extended release tablet oral Daily
  • 8.5 mg extended release tablet oral Daily
  • 17 mg extended release tablet oral Daily
  • 25.5 mg extended release tablet oral Daily                                                         
  • 34 mg extended release tablet oral Daily

amlodipine (Norvasc)

  • 2.5 mg tablet oral Daily
  • 5 mg tablet oral Daily
  • ONE 5 mg tablet oral PLUS ONE 2.5 mg tablet oral (Total: 7.5 mg) Daily
  • 10 mg tablet oral Daily
  • 2.5 mg tablet oral Daily
  • 5 mg tablet oral Daily
  • ONE 5 mg tablet oral PLUS ONE 2.5 mg tablet oral (Total: 7.5 mg) Daily
  • 10 mg tablet oral Daily

Reviewed: March 23, 2005 and July 29, 2008 (Sular)

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved